Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Date:8/29/2007

/p>

will highlight outcomes within the high-risk diabetic subset. The

Company plans to issue a press release at this time.

Tuesday, September 4

-- TAXUS II long-term data. At 9:45 a.m., five-year clinical follow-up

results from the TAXUS II clinical trial will be presented by Antonio

Colombo, M.D., the study's principal investigator, in the Helsinki Room

(Zone 2). TAXUS II is a randomized, double-blind, controlled study of

the safety and efficacy of the TAXUS Paclitaxel-Eluting Coronary Stent,

in which two sequential cohorts of patients with standard risk, de novo

coronary artery lesions were treated with different dose formulations

versus a bare-metal stent control group. The Company plans to issue a

press release at this time.

-- Cardiac Rhythm Management Workshop Session. At 12:45 p.m., the Company

will host a workshop entitled "Cardiac Resynchronisation Therapy: all

you need to know to maximize patient follow-up," in the Cairo Room

(Zone 2). The session will address the current status of CRT, the

value of HF diagnostics after device implant, and hemodynamic

optimization during CRT.

-- Symposium on Drug-Eluting Stents. At 2:00 p.m., the Company will host

a symposium entitled "What's the evidence for using drug-eluting stents

in your patients," chaired by H.D. Glogar, M.D., and Donald S. Baim,

M.D., in the Brussels Room (Zone 4). The symposium will focus on

current treatment options for coronary artery disease, latest

challenges in ULMCA (Unprotected Left Main Coronary Artery) with PCI,

evidence-based medicine for diabetics, real world data, and future

outlook for DES.

Wednesday, September 5

-- TAXUS in Women study. Results from the TAXUS WOMAN study, a gender

specific sub-group analysis of the TAXUS II - VI trials
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
7. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Inspire Announces Presentations at Two European Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DALLAS , Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com ... to its store . (Photo: ... consumption upgrade and policy support, China,s ... the years, with total market size rising from 3.28 ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( ... "Dental Consumables Market - Global Industry Analysis, Size, Share, ... to their offering. (Logo: ... which are used on patients in order to treat ...
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... Study Ingredient,s, Impact on North Americans, NEW ... of,Japan today announced that it has selected world-renowned Cardiologist ... KGK Synergize Inc.,to launch a new clinical trial to ... lipid management and the reduction of cardiovascular,risk factors in ...
... a 52-week phase 3,study (LEADTM 3) of Novo ... GLP-1 analog, were published online today in The ... produces statistically,significant and sustained improvements in blood sugar ... compared with glimepiride, a widely used,oral anti-diabetic drug. ...
Cached Medicine Technology:Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels 2Leading Cardiologist Joins Ontario Research Firm to Conduct New Clinical Trial on the Effect of Pantethine on Cholesterol Levels 3Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 3
(Date:7/11/2014)... Steven Reinberg HealthDay Reporter ... depression may increase the risk for stroke, a new study ... the risk of a stroke or a transient ischemic ... apparently raised stroke or TIA risk by 59 percent. And ... a mini-stroke caused by a temporary blockage of blood flow ...
(Date:7/11/2014)... the distinguished wedding dress manufacturer and retailer, has recently ... . To top it all off, all these high ... to 65% off. Clients who place orders on the ... Fadhits.com is devoted to designing and selling beautiful wedding ... All its items come with very fast delivery. More ...
(Date:7/11/2014)... San Francisco shows that an "expressive therapy" group ... living with HIV disclose their health status and ... and quality of their relationships., "Medication alone is ... L. Machtinger, MD, director of the Women,s HIV ... patients are on effective antiretroviral therapy but far ...
(Date:7/11/2014)... 11, 2014 Bedros Keuilian is known in ... he’s earned by founding the fast-selling fitness franchise in the ... businesses. He works with successful boot camp owners on a ... the traits of the most successful boot camp owners , ... qualities. , “I’ve worked with and coached some of the ...
(Date:7/11/2014)... When the mercury rises, heat can strain the limits of ... on a heavier load in hot weather to keep body ... Harvard Men's Health Watch . , For otherwise fit, ... their limits and drinking enough fluids. But what about men ... to the heat," says Dr. Joanne Foody, Director of cardiovascular ...
Breaking Medicine News(10 mins):Health News:Stress, Depression May Boost Stroke Risk, Study Finds 2Health News:Stress, Depression May Boost Stroke Risk, Study Finds 3Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 2Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 3
... is a form of arthritis where one or more ... in these type of joint problems is the loss ... that moisturizes the area. This fluid is called synovial ... since 1987, after the therapy was proved beneficial in// ...
... Institute, has succeeded in finding a new biosensor ... a breakthrough technology that will help scientific researchers ... of neurons, nerve tissue and organic neural networks. ... metal oxide semiconductor technology extended with additional process ...
... currently testing the safety of hypothermia as a ... treatment has been shown to be effective for ... effectiveness in treating children with traumatic brain injuries ... excitotoxicity (excessive neurotransmitters released with injury that damage ...
... of Durham in England has reported a discovery, that adds ... ones, for breast feeding of babies. Babies who are breast-fed ... than babies who are bottle-fed in bed. The study included ... while they slept. Researchers found that mothers who breast-fed their ...
... received a patient, a two-month-old baby with white blood! The ... caused due to a deficiency of lipoprotein lipase. This disease ... said that the baby was brought to the hospital with ... boy child, was found to have lipemic blood. Doctors said ...
... study published in the journal, Molecular Psychiatry suggested that scientists ... to sleepwalking. Sleepwalking is a complex disorder and affects around ... of adults. Though the condition is harmless, it may sometimes ... others. Scientists examined a family of genes known as HLA ...
Cached Medicine News:
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: